Financial Overview and Strategic Insights
JV Structure and Licenses
Strategic JV with Kibbutz Gan Shmuel, a commercial
kibbutz and food company.
CRONOS ISRAEL
Israel Market
Israel is a leader in research and development on
medical cannabis.
Cronos' revenue within Israel was $21.1 million in 2023.
Cronos Group
Ownership Interest
Subsidiaries
Cronos Israel G.S. Cultivation Ltd.
70%
CRONOS
ISRAEL
Currently in market with PEACE NATURALS® and LITTM
branded cannabis products.
Cronos Israel G.S. Manufacturing Ltd.
90%
90%
Cronos Israel G.S. Store Ltd.
Cronos Israel G.S. Pharmacy Ltd.
90%
The Company has the necessary regulatory
approvals to produce, manufacture and sell dried
cannabis flower, pre-rolls and oil products.
Facility
Ideal climate enables efficient production of
high-quality cannabis.
Over 1,000 agriculturally skilled Kibbutz
members live on site and existing infrastructure
available to support operations.
Gan Shmuel currently exports to 35 countries
across Europe and Asia through Gan Shmuel
Foods Ltd., a publicly traded food company
listed on the Tel Aviv Exchange.
CRONOS
THICK
T15/C3
THCOTE
PEACENATURALS
go
גיי אט קוס
GS KUSH
Additional Partnerships: Cannasoul Analytics
In April 2020, Cronos Israel entered into a
collaboration agreement with Cannasoul Analytics
Ltd. ("Cannasoul"), a cannabis research company
dedicated to developing scientific intellectual
property, medical products, and technologies, to
develop a commercial cannabis analytical testing
laboratory onsite at Cronos Israel.
Cannasoul intends to operate the laboratory and
conduct in-house commercial analytical testing for
Cronos Israel and third-party clients.
CANNASOUL
Analytics
12View entire presentation